Blood‐based metabolic signatures in Alzheimer's disease

Blood‐based metabolic signatures in Alzheimer's disease

Abstract Introduction Identification of blood‐based metabolic changes might provide early and easy‐to‐obtain biomarkers. Methods We included 127 Alzheimer's disease (AD) patients and 121 control subjects with cerebrospinal fluid biomarker‐confirmed diagnosis (cutoff tau/amyloid β peptide 42: 0....

Full description

Bibliographic Details
Main Authors: Francisca A. deLeeuw, Carel F.W. Peeters, Maartje I. Kester, Amy C. Harms, Eduard A. Struys, Thomas Hankemeier, Herman W.T. vanVlijmen, Sven J. van derLee, Cornelia M. vanDuijn, Philip Scheltens, Ayşe Demirkan, Mark A. van deWiel, Wiesje M. van derFlier, Charlotte E. Teunissen
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Alzheimer's disease
Amino acids
Biomarkers
Graphical modeling
Metabolomics
Oxidative stress
Online Access:https://doi.org/10.1016/j.dadm.2017.07.006

Internet

https://doi.org/10.1016/j.dadm.2017.07.006

Similar Items